128 results
Page 2 of 7
8-K
EX-99.1
vswgaw4i c29b4
14 Jun 23
NanoVibronix Announces Distribution Agreement with Sports Medicine Supplier Mio-Guard
8:30am
DEFA14A
EX-99.1
4077 iakd
18 May 23
Additional proxy soliciting materials
8:32am
8-K
EX-99.1
v0ocr
18 May 23
NanoVibronix Issues Letter to Shareholders
8:30am
8-K
EX-99.1
ool4ozjtf1pu5ncv
15 Dec 22
Nanovibronix Announces Results of Annual Meeting of Stockholders Held Today
5:29pm
8-K
EX-99.1
p6ls 4vg88
1 Dec 22
NanoVibronix Announces $2.4 Million Registered
6:06am
424B5
xxl433db9
30 Nov 22
Prospectus supplement for primary offering
5:29pm
8-K
EX-99.1
h9avi
29 Nov 22
NanoVibronix Receives FDA 510(k) Premarket Clearance for PainShield Plus
9:13am
8-K
EX-99.1
2793zk2r7sqq
16 Nov 22
NanoVibronix Announces Interim Results of Clinical Study for UroShield
8:30am
DEFA14A
npaitthp
15 Nov 22
Additional proxy soliciting materials
9:26am
8-K
EX-99.1
a12igt5yxt np1a
19 Oct 22
NanoVibronix Receives Extension to Satisfy Nasdaq Price Requirement
8:30am